|
CN103211770A
|
|
Igutimod slow release multielement composition and preparation method thereof
|
|
CN104055758A
|
|
Pharmaceutical composition and application of same in preparation of medicines used for treating scalds
|
|
CN104045713A
|
|
Anti-Blys monoclonal antibody and pharmaceutical composition containing anti-Blys monoclonal antibody
|
|
CN103127112A
|
|
Application of quinolinone derivatives in tumor treatment
|
|
CN104007185A
|
|
HPLC determination method for detecting impurities in zanamivir and zanamivir-containing preparation
|
|
CN103113375A
|
|
Pyrazolo [3, 4-d] pyrimidine compounds and preparation method thereof
|
|
CN104003990A
|
|
Heterocyclic amine Hedgehog signal path inhibitor
|
|
CN104004814A
|
|
Method for precisely controlling monoclonal antibody product quality through animal cell fed-batch cultivation
|
|
CN103910736A
|
|
Dihydropyran pyrimidine derivatives and pharmaceutical application thereof
|
|
CN103006661A
|
|
Preparation containing lurasidone hydrochloride and preparation method thereof
|
|
CN103772408A
|
|
Crystal of prasugrel-1,5-napadisylate
|
|
CN103709172A
|
|
Substituted furan-piperidine derivative and application thereof
|
|
CN102766139A
|
|
Azilsartan polymorphic substance and preparation method thereof
|
|
CN102731408A
|
|
Azilsartan intermediate and preparation method thereof
|
|
CN102895176A
|
|
Method for preparing porous gel containing recombinant human endostatin
|
|
CN102627610A
|
|
One type of benzimidazole derivatives and application thereof
|
|
CN102617599A
|
|
Macrocyclic compound and application thereof
|
|
CN102627620A
|
|
One type of benzofuran derivatives and medical application thereof
|
|
CN102617502A
|
|
Benzoxazole derivatives and application of benzoxazole derivatives to medicines
|
|
CN102580097A
|
|
Medicinal composition containing azilsartan
|
